Sign In

Anna Perdrix Rosell

Founder and co-CEO at Sixfold Bioscience.

Professional Background

Anna Perdrix Rosell is a distinguished leader in the field of biotechnology and cancer research, equally adept in business strategies and scientific inquiry. Her extensive career combines clinical research, entrepreneurial ventures, and a commitment to advancing innovation in biomedicine. Anna's professional journey showcases her ability to bridge the gap between technology and health care, making significant contributions to both fields.

Having co-founded Sixfold Bioscience, a cutting-edge organization at the intersection of biology and data science, Anna has played a pivotal role in developing biotechnologies that promise to transform patient care and streamline research. Her leadership in various organizations, such as her tenure with the Engineering Biology Steering Group at the Department for Science, Innovation and Technology, underscores her influence in shaping policy and direction in the life sciences sector.

Anna's impressive portfolio includes accolades such as being recognized in Forbes 30 Under 30, a testament to her entrepreneurial spirit and early career success. This achievement not only highlights her innovative approach to biotechnology but also cements her status as a thought leader among the next generation of scientists and entrepreneurs.

With a strong academic and professional background, Anna has also contributed to numerous committees and advisory boards, including her role with the Engineering Biology Advisory Committee (EBAC) at the BioIndustry Association (BIA) and serving on the Board of Advisors at Newcastle University. These positions reflect her dedication to fostering collaboration in the scientific community and empowering the future of biotechnology.

Education and Achievements

Anna’s academic credentials are as impressive as her professional milestones, showcasing a deep-rooted commitment to education, research, and innovation. She has pursued an array of studies, starting with a Bachelor of Science in Biomedical Sciences from the Universitat de Barcelona. This foundational education laid the groundwork for her subsequent advanced degrees and her lifelong passion for cancer research.

Continuing her education at King’s College London, Anna obtained both a Master of Research in Translational Cancer Medicine and a Doctor of Philosophy (Ph.D.) in Cancer Research. Her rigorous academic training equipped her with vital skills in research methodologies, critical thinking, and scientific analysis, all of which have been instrumental in her contributions to the field.

To further enhance her leadership capabilities, Anna studied Executive Leadership Development at Stanford University Graduate School of Business, where she refined her skills in managing complex organizations and driving innovative projects. Further refinement of her business acumen was achieved through an MBA at Quantic School of Business and Technology and participation in the Accelerate programme focused on Biotech Business Development at the prestigious Cambridge Judge Business School. Additionally, her experience at Y Combinator, one of the most renowned startup accelerators, honed her entrepreneurial skills.

Recognizing the importance of interdisciplinary approaches to solving pressing health problems, Anna's varied educational experiences have significantly shaped her multifaceted perspective on biotechnology and healthcare.

Achievements

Anna Perdrix Rosell's journey is characterized by an impressive series of accomplishments and contributions to the scientific and business communities. Her recognition as part of Forbes 30 Under 30 exemplifies her potential to make lasting impacts in the industries she is passionate about.

Her roles in various organizations speak volumes about her leadership and expertise. As a former SME leader at the Royal Academy of Engineering, Anna demonstrated her ability to advocate for small and medium-sized enterprises in the engineering sector, emphasizing innovation and growth.

Her past membership in esteemed organizations such as the Engineering Biology Steering Group and the Engineering Biology Advisory Committee highlights her strategic insights and commitment to the advancement of engineering biology for the benefit of society. Furthermore, her experience as a research associate at prestigious institutions like King's College London and Breakthrough Breast Cancer solidifies her role as a skilled researcher who has significantly contributed to the understanding of cancer mechanisms and treatment approaches.

Anna's internship experiences, such as her Medical Exchange Internship with the International Federation of Medical Students' Associations and previous roles as a research intern at Oxitec Ltd and a research assistant at IRB Barcelona, illustrate her proactive approach in seeking opportunities to expand her knowledge and expertise.

Through these achievements, Anna has not only made significant scientific contribut

Anna Perdrix Rosell
Add to my network

Location

Greater London, England, United Kingdom